We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $2.2B
1-Year Est. Return 156.35%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+156.35%
3 Year Est. Return
+492.92%
5 Year Est. Return
+804.3%
10 Year Est. Return
+3,997.35%
AUM
$193M
AUM Growth
-$22.9M
Cap. Flow
-$75M
Cap. Flow %
-38.89%
Top 10 Hldgs %
99.96%
Holding
13
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
LJPC
La Jolla Pharmaceutical Company
LJPC
+$10.2M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$8.13M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$3.07M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.86%
2 Healthcare 42.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLXP
1
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$46.9M 24.29%
300,000
– –
HRTX icon
2
Heron Therapeutics
HRTX
$60.3M
$41M 21.23%
4,919,625
– –
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$18.4M 9.52%
1,911,462
+1,029,555
+117% +$10.2M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$12.5B
$13.2M 6.82%
182,300
– –
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.05M 2.62%
288,432
– –
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.68M 1.91%
300,000
-700,000
-70% -$8.13M
PHIO icon
7
Phio Pharmaceuticals
PHIO
$11.6M
– –
0
– –
DNDN
8
DELISTED
DENDREON CORPORATION
DNDN
$80K 0.04%
55,548
– –
ECYT
9
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-465,763
Closed -$3.07M
AMBI
10
DELISTED
Ambit Biosciences Corp
AMBI
$0 ﹤0.01%
46
– –

Similar funds

LI
Leeward Investments Boston, Massachusetts $2.2B AUM 46.08% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
1SB
1ST Source Bank South Bend, Indiana $2.21B AUM 28.75% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.2B AUM 1.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $2.21B AUM 22.85% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Tang Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Tang Capital Management held 13 positions worth $193M, down 11% from $216M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $75M in Q3 2014, closing 1 position and reducing 1 holding. Its most notable exit was Endocyte, Inc. Common Stock, an estimated $3.07M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 52% a quarter earlier, followed by Healthcare.

Against the trend, Tang Capital Management added an estimated $10.2M to La Jolla Pharmaceutical Company.

  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q3 2014, an estimated $10.2M increase.
  • Tang Capital Management's biggest Q3 2014 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $8.13M.
  • Tang Capital Management fully exited Endocyte, Inc. Common Stock in Q3 2014, selling an estimated $3.07M.
  • Tang Capital Management's ten largest holdings make up 100% of its $193M portfolio in Q3 2014.
  • Tang Capital Management opened 0 new positions and closed 1 in Q3 2014.
  • Tang Capital Management's portfolio value fell 11% quarter-over-quarter to $193M.

Based on Tang Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.